Early assessment of clofarabine effectiveness based on measurable residual disease, including AML stem cells

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)1694-1697
Number of pages4
JournalBlood
Volume137
Issue number12
Early online date10 Nov 2020
DOIs
Publication statusPublished - 25 Mar 2021

Cite this